All News

Galcanezumab demonstrated clinically and statistically significant benefits across several migraine-relevant outcomes when compared to placebo.

The CDC reported Thursday suicide rates have been rising in nearly every state between 1999 and 2016, finding that suicide rates increased more than 30% in half of states.

The authors speculated that some cancer regimens, such as those with corticosteroids, cause hyperglycemia.

President Trump has signed off on a bill to expand private care access for veterans; the Michigan House passed a revised Medicaid work requirement bill; and HHS will allow insurers to use a workaround for 2019 prices.

Two recent studies examined issues related to asthma statistics and treatment: is mortality underrepresented due to how death certificates are recorded? How well do providers adhere to clinical guidelines for asthma?

Among HIV-positive women with diabetes, HIV control has improved over time, but diabetes control has not.

More female than male adults visited office-based doctors in 2015, a CDC report noted Tuesday, and chronic conditions made up the largest category of visits. The data brief from the National Center for Health Statistics gave insight into who went to office-based providers that year and why, and which services were offered and who paid for them.

A study recently published in Cell investigated the deletion of the CD33 protein to enable CAR T-cells to more accurately target and attack cancerous cells in patients with n acute myeloid leukemia (AML).

While it is well understood that, in the general population, regular exercise is associated with a reduced risk of death, less is known about whether exercise is similarly beneficial for adult survivors of childhood cancer who may already have an increased risk of death and a shortened life expectancy because of late effects of treatment.

The Senate Judiciary Committee has scheduled a vote for the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act; the FDA is targeting websites illegally marketing and selling opioids; and the White House has dropped its proposal to cut Ebola funding amid the outbreak in Congo.

The fact that trust cannot be purchased highlights an important truth: trust needs to be earned. And healthcare professionals have earned it.

A study of baseline characteristics and spending of hospitals participating in Medicare's voluntary and mandatory orthopedic bundled programs found that there were few differences, indicating that mandatory programs could engage more hospitals that otherwise would not have participated in voluntary programs.

Pulmonary hemosiderosis (PH) is a rare, chronic lung disease characterized by hemoptysis, iron deficiency anemia, and alveolar and/or interstitial opacities on lung imaging. Little about the etiology and pathophysiology of the disease is known, but PH typically involves periods of remission and relapse. New research that investigated the relationships between PH and Down syndrome (DS), and found that patients with DS have a higher risk of developing PH.

The estimate includes the average cost of healthcare paid by both employers and employees through insurance, deductibles, and out-of-pocket costs.

Trustees for Medicare said that Medicare Part A, which covers hospital bills, will become insolvent in 2026, 3 years earlier than the projection last year. In its annual report, the trustees cited lower payroll taxes attributable to lowered wages in 2017, lower levels of projected gross domestic product, and lower income from the taxation of Social Security benefits as a result of the tax-reform package President Trump signed into law in December 2017.

The interim analysis of the phase 3 A.R.R.O.W. trial found that once-weekly carfilzomib at 70 mg/m2 had superior progression-free survival and overall response rates compared with twice-weekly carfilzomib at 27 mg/m2.

Repealing or phasing out Medicaid expansion could reverse improvements in quality and service use and could be particularly harmful to low-income rural populations, said the authors of a study looking at the effect of Medicaid on community health centers.

National efforts to reduce hospital-acquired conditions (HACs), such as infections, adverse drug events, and injuries from falls, helped prevent an estimated 8000 inpatient deaths and save $2.9 billion between 2014 and 2016, according to a report released Tuesday from the Agency for Healthcare Research and Quality (AHRQ).

In healthcare, brokers help most companies buy, manage, and choose healthcare plans. But, judging by rates of change, spending trends, and objectivity, it’s debatable where they’re adding value and how keen their eye is for innovation.

A state judge in Maine ordered Goveror Paul LePage’s administration to stop stalling and implement a Medicaid expansion; the National Institutes of Health reported on a treatment that eradicated cancer from a patient who had untreatable, advanced breast cancer; citing changes to the Affordable Care Act, insurers are proposing double-digit rate hikes for 2019.

CMS Monday released a scorecard that reports quality metrics voluntarily reported by states for Medicaid and the Children’s Health Insurance Program (CHIP), as well as federally reported measures, but the association that represents state Medicaid directors expressed some concerns with the scorecard’s data and what sorts of conclusions may be drawn from them, given the huge variability of state programs, essentially giving it a score of “needs improvement.”

Deaths from treatable conditions may cost the world $6 trillion a year in lost economic welfare, according to a study led by Harvard Medical School researchers and published in the June issue of Health Affairs. Eight million deaths could have been avoided in 2015 with proper access to high-quality medical care.

A new study published in Health Affairs hopes to provide an explanation of the evidence for the pros and cons of Medicaid expansion as part of the Affordable Care Act (ACA) with a systematic literature review, finding that expansion was associated with increases in coverage, service use, quality of care, and Medicaid spending.

In a recent study published in the Journal of Experimental Medicine, researchers found that fingolimod (sold as Gilenya), an FDA-approved orally administered drug to treat multiple sclerosis, could reduce painful side effects of multiple myeloma treatments.

Public health messaging has typically focused on the volume of walking not the intensity. This study suggests for those with limited time, a faster pace could make a difference.

An experimental drug for patients with acute myeloid leukemia (AML) with mutations in the gene encoding isocitrate dehydrogenase 1 (IDH1) was found to be safe with durable remissions.

Heath advocates in other states are hopeful about Medicaid expansion after Virginia expanded healthcare for the poor last week; prices of drugs containing estradiol have doubled in the past 5 years; an entrepreneur from Colorado is pitching a plan to save a tiny, bankrupt rural hospital in California by using the 26-bed hospital to bill insurers for lab tests via telemedicine.

A high assessment test score for chronic obstructive pulmonary disease (COPD) may predict anxiety in patients, a recent study reported.

The FDA has granted a Breakthrough Therapy designation to bluebird bio, Inc’s Lenti-D, a gene therapy for patients with cerebral adrenoleukodystrophy, an X-linked genetic disorder caused by a defect in the gene ABCD1.

Two abstracts presented at the International Society of Pharmacoeconomic and Outcomes Research Annual International Meeting highlighted patient experiences in blood cancers. One highlighted the worries of patients with acute myeloid leukemia, and the other analyzed economic burdens and resource utilization for patients with non-Hodgkin lymphoma.